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Abstract. Hemophagocytic lymphohistiocytosis (HLH) and rhabdomyolysis are rare complications of typhoid fever
from Salmonella enterica serovar Typhi. Herein, we describe the clinical features in a 21-year-old female from India
who presented to the intensive care unit with fever, severe pancytopenia, and rhabdomyolysis.
INTRODUCTION
Typhoid fever (TF) remains to be an important etiology of
fever in developing countries, with an estimated 13.5 million
episodes in 2010.1 The course of TF can range from an uncom-
plicated febrile illness to life-threatening sepsis with multiorgan
involvement. We report a previously healthy Indian female
with severe TF complicated by sepsis with multiple organ
dysfunction syndrome, rhabdomyolysis, and hemophagocytic
lymphohistiocytosis (HLH).
CASE REPORT
A previously healthy 21-year-old Indian woman from south-
ern India presented to our hospital with fever and confusion
that began 2 days after her arrival from India. She also
complained of fatigue, myalgia, and non-bloody, watery diar-
rhea, occurring three to five times a day. She denies eating
uncooked food and food prepared outside her home, or any
contact with animals. No other family member or immediate
contacts in India or in the United States developed similar
symptoms. Her journey began from Vijayawada to Chennai,
India, and her airline transit occurred through London,
United Kingdom.
On admission, her vital signs were: temperature 39.5°C,
blood pressure 88/44 mmHg, heart rate 158 beats/minute, respi-
ratory rate 39 breaths/minute, and oxygen saturation of 95%
on room air. Physical examination was remarkable for dry
mucous membranes, mild muscle tenderness, splenomegaly,
tea-colored urine, and disorientation. Otherwise, she had no
edema, lymphadenopathy, abdominal tenderness, or skin rash.
Laboratory investigations were significant for pancytopenia
with white cell count 0.9 × 109/L (absolute neutrophil count
500/mm3), hemoglobin 11.6 g/dL (nadir of 7.9), and platelet
count 6 × 109/L, acute kidney injury with an elevated serum
creatinine of 1.37 mg/dL (peak of 1.64), hypokalemia (nadir of
2.6 mmol/L), serum bicarbonate of 12 mmol/L, rhabdomyolysis
with creatine phosphokinase (CPK) of 83,550 U/L, and urinaly-
sis showing 3+ blood. She was human immunodeficiency virus
negative, and workup for other infectious etiologies were nega-
tive, including Ehrlichia PCR; dengue IgM; Leptospira serology
and urine culture; hepatitis A, B, C, and E panel; and malaria
rapid antigen and smear. She was started empirically on intra-
venous vancomycin, cefepime, and doxycycline. Two sets of
blood culture and stool culture grew Salmonella enterica serovar
Typhi (Salmonella typhi), and her antibiotics were eventually
de-escalated to intravenous ceftriaxone. Disk diffusion method
for susceptibility performed by the Center for Disease Control
disclosed the S. typhi to be susceptible to ampicillin, ceftriaxone,
cefazolin, chloramphenicol, and trimethoprim–sulfamethoxazole,
but had intermediate resistance to ciprofloxacin.
With regard to her pancytopenia, patient had a negative
workup for hemolysis, however, she fulfilled the diagnostic
criteria for HLH: presence of fever, splenomegaly, ferritin level
of 838 ng/mL, and a soluble interleukin-2 receptor (IL-2R)
level of 2,939 U/mL (reference range 45–1,105 U/mL). Her pan-
cytopenia eventually improved with antibiotics as is expected
for infection-associated HLH (IAH). Her renal function also
improved with hydration and antibiotics. She was discharged on
trimethoprim–sulfamethoxazole 160mg/800mg two tablets twice
daily to complete a total of 2 weeks.
DISCUSSION
TF by S. typhi can result in severe disease with complications
in 10–15% of patients, including gastrointestinal bleeding,
intestinal perforation, hepatitis, pancreatitis, typhoid encepha-
lopathy, disseminated intravascular coagulation, hemolytic ure-
mic syndrome, endocarditis, pneumonia, and rarely, reactive
HLH and rhabdomyolysis such as in our patient.2,3 Host factors
associated with severe disease have been reported in younger
individuals (birth through 1 year of age), the immunosup-
pressed, females, and those infected with resistant S. typhi.3,4
Specific genetic polymorphisms in major histocompatibility
complex class II and III genes have also been found in individ-
uals with severe TF.5,6
IAH has been most commonly associated with viral infec-
tions, especially Epstein–Barr virus (EBV), but has also been
reported with pyogenic infections.7,8 IAH as a complication
of typhoid is rarely reported. The incidence is unknown in
the United States, but in a case series of 30 patients in India,
two of IAH cases were in patients with TF.8 The pathophysi-
ology of IAH is poorly understood, but it is suggested to be
due to hypersecretion of cytokines by persistently activated
lymphocytes and histiocytes. HLH is diagnosed using clinical
and molecular criteria. Five of eight clinical findings required
are fever; splenomegaly; cytopenia; hypertriglyceridemia and/or
hypofibrinogenemia; demonstration of hemophagocytosis in
bone marrow, spleen, or lymph nodes; decreased natural killer
cell function; elevated ferritin level; and an elevated soluble
CD25 or IL-2Rα chain ≥ 2,400 IU/mL.7 Sixty to seventy
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percent of patients with IAH respond to supportive care and
treatment of the underlying infection, but severe cases, espe-
cially those associated with EBV, have required chemotherapy.7
The second unusual feature about this case is the degree of
rhabdomyolysis seen in the setting of enteric fever. Rhabdo-
myolysis has been reported in bacterial sepsis, and in a retro-
spective study in 103 patients from India, 33% were noted to
be in patients with gram-negative sepsis. However, S. typhi
was not isolated in their cohort, and the mean serum CPK of
7,114 IU/L was much lower than in our patient.9 In a review
of literature from 1996, Salmonella spp. was found to be the
fourth most commonly cited cause of bacteria-induced rhab-
domyolysis, with 67% of the cases leading to acute kidney
injury.10 There have been 22 case reports of Salmonella infec-
tion in the United States causing rhabdomyolysis, but only
two of these were due to S. typhi, with the majority being
caused by non-typhoidal strains.11,12 It should be noted that in
all the cases, rhabdomyolysis was noted when patients were
bacteremic. Mechanisms proposed include sepsis causing tis-
sue hypoxia, direct muscle invasion by bacteria, and altered
metabolic activity of involved muscles.13 Despite its rarity, TF
should be included in the differential diagnosis of myositis or
rhabdomyolysis in foreigners or returning travelers and should
be managed with treatment of an appropriate antibiotic and
adequate hydration to prevent complications.
CONCLUSION
TF should be suspected in returned travelers or foreigners
from endemic countries presenting with severe febrile illness
complicated by pancytopenia and myalgia, which could be
IAH and rhabdomyolysis, respectively. Recognition is impor-
tant for prompt diagnosis and treatment with an appropriate
antibiotic to prevent complications and increased mortality.
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